NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
The Nanotechnology Characterization Laboratory (NCL) has developed a standardized analytical assay cascade to assist nanotechnology-based drug and device developers with preclinical characterization aimed at defining nanoparticle physicochemical properties, immunological compatibility, general toxicity, and pharmacology. Such characterization is essential for the translation of nanotechnology formulations from the discovery phase into clinical trials. The protocols were developed in close collaboration with the US Food and Drug Administration (US FDA) and the National Institute of Standards and Technology (NIST) and used since 2005 to characterize over a thousand nanoformulations, including but not limited to lipid nanoparticles, liposomes, polymeric micelles, metal colloids and metal oxides, carbon nanotubes, fullerenes, dendrimers, and nucleic acid nanoparticles. The protocols can also be used for characterization of nanomaterials for other types of non-clinical studies.
Contents
- Immunology protocols
- NCL Method ITA-37.2. Immunophenotyping: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells: Version 3Hannah S. Newton, Jenny Zhang, and Marina A. Dobrovolskaia.Published: November 2023.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation of Reagents and Controls
- 5. Preparation of Nanoparticles
- 6. NovoCyte 3005 Instrument Settings
- 7. Experimental Conditions Necessary for Preparation of Immunophenotyping Panels #1 and #2
- 8. Collection and Handling of Whole Blood (Day 1)
- 9. Preparation of PBMC
- 10. Experimental Procedure for Nanomaterial Treatment of PBMC (24-well)
- 11. Experimental PBMC Staining Procedure (Day 2)
- 12. Data Acquisition on Novocyte 3005 (Day 3)
- 13. Data Analysis of Immunophenotyping Panels with FCS Express
- 14. References
- 15. Abbreviations
- NCL Method ITA-37.1. Immunophenotyping: Instrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures: Version 3Hannah S. Newton, Jenny Zhang, and Marina A. Dobrovolskaia.Published: November 2023.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation of Reagents and Controls
- 5. NovoCyte 3005 Instrument Settings
- 6. Flow Cytometry Control Experiments with Compensation Beads for Antibody Titration and Single Stain Controls
- 7. Flow Cytometry Control Experiments with PBMC (FMO Controls) (2 Day procedure per panel)
- 8. References
- 9. Abbreviations
- 10. Appendix
- NCL Method ITA-29. Detection of nanoparticles’ ability to stimulate toll-like receptors using HEK-Blue reporter cell lines: Version 2Edward Cedrone and Marina A. Dobrovolskaia.Published: January 2023.
- NCL Method ITA-14. Analysis of Nanoparticle Effects on Maturation of Monocyte Derived Dendritic Cells In Vitro: Version 5Timothy M. Potter, Edward Cedrone, Barry W. Neun, Susan L. Strobl, Liubov Zaritskaya, and Marina A. Dobrovolskaia.Published: November 2022.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Preparation of Reagents
- 5. Preparation of Test Nanoparticles
- 6. Isolation of Human PBMC from Leukopack or Whole Blood
- 7. Rapid Thaw Method of Cryopreserved PBMC
- 8. Generation of Immature Dendritic Cells
- 9. Maturation of Dendritic Cells with or without Nanomaterial
- 10. Analysis of DC Maturation by Flow Cytometry
- 11. Abbreviations
- 12. References
- 13. Appendix
- NCL Method ITA-40. Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages: Version 2Edward Cedrone, Martin Schuster, Rosemarie Preyer, and Marina A. Dobrovolskaia.Published: October 2022.
- NCL Method ITA-7. Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7: Version 2Timothy M. Potter, Edward Cedrone, Barry W. Neun, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method ITA-27. Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human Cytokines in Culture Supernatants: Version 1Edward Cedrone, Timothy M. Potter, Barry W. Neun, Abby Tyler, and Marina A. Dobrovolskaia.Published: September 2020.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation of Reagents and Controls
- 5. Preparation of Inhibition/Enhancement Controls (IECs)
- 6. Experimental Procedure for 4-plex Interferon Multiplex
- 7. Experimental Procedure for 14-plex and 15-plex multiplex
- 8. Acceptance Criteria
- 9. Example of ELISA Plate Template
- 10. Example of Product Information Card
- 11. References
- 12. Abbreviations
- NCL Method ITA-36. Detection of Naturally Occurring Antibodies to PEG and PEGylated Liposomes in Plasma of Human Donor Volunteers: Version 2Barry W. Neun and Marina A. Dobrovolskaia.Published: June 2020.
- NCL Method ITA-25. Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNγ in Culture Supernatants: Version 3Edward Cedrone, Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation and Storage of Plasma for Preparation of Assay Diluent
- 5. Preparation of Reagents and Controls
- 6. Preparation of Calibration Standard and Quality Controls for ELISA
- 7. Experimental Procedure
- 8. Acceptance Criteria
- 9. Example of ELISA Plate Template
- 10. Abbreviations
- NCL Method ITA-24. Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human TNF-α in Culture Supernatants: Version 3Edward Cedrone, Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation and Storage of Plasma for Preparation of Assay Diluent
- 5. Preparation of Reagents and Controls
- 6. Preparation of Calibration Standard and Quality Controls for ELISA
- 7. Experimental Procedure
- 8. Acceptance Criteria
- 9. Example of ELISA Plate Template
- 10. Abbreviations
- NCL Method ITA-23. Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-1β in Culture Supernatants: Version 3Edward Cedrone, Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation and Storage of Plasma for Preparation of Assay Diluent
- 5. Preparation of Reagents and Controls
- 6. Preparation of Calibration Standard and Quality Controls for ELISA
- 7. Experimental Procedure
- 8. Acceptance Criteria
- 9. Example of ELISA Plate Template
- 10. Abbreviations
- NCL Method ITA-22. Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IL-8 in Culture Supernatants: Version 3Edward Cedrone, Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- 1. Introduction
- 2. Principle
- 3. Reagents, Materials, and Equipment
- 4. Preparation and Storage of Plasma for Preparation of Assay Diluent
- 5. Preparation of Reagents and Controls
- 6. Preparation of Calibration Standard and Quality Controls for ELISA
- 7. Experimental Procedure
- 8. Acceptance Criteria
- 9. Example of ELISA Plate Template
- 10. Abbreviations
- NCL Method ITA-17. Analysis of Nanoparticle Effects on Leukocyte Procoagulant Activity: Version 3Timothy M. Potter, Edward Cedrone, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- NCL Method ITA-12. In Vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time: Version 3Edward Cedrone, Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- NCL Method ITA-11. Measurement of Nanoparticle Effects on Cytotoxic Activity of NK Cells by Label-Free RT-CES System: Version 3Timothy M. Potter, Edward Cedrone, Barry W. Neun, and Marina A. Dobrovolskaia.Published: June 2020.
- NCL Method ITA-9.2. In Vitro Assay for Assessing Nanoparticle Effects on Monocyte/Macrophage Phagocytic Function: Version 1Timothy M. Potter, Edward Cedrone, Barry W. Neun, and Marina A. Dobrovolskaia.Published: May 2020.
- 1. Introduction
- 2. Principles and Limitation
- 3. Reagents, Materials, Cell Lines, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Study Samples
- 6. Cell Preparation
- 7. Experimental Procedure, Day 1
- 8. Experimental Procedure, Day 2
- 9. Calculations
- 10. Acceptance Criteria
- 11. References
- 12. Abbreviations
- 13. Appendix
- NCL Method ITA-9.1. Phagocytosis Assay: Version 1.2Timothy M. Potter, Edward Cedron, Barry W. Neun, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-8.2. Analysis of Nanoparticle Chemoattractant Properties Using Label-Free, Real-Time Chemotaxis Assay: Version 1.0Edward Cedrone, Julia Bui, Naichen Yu, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-8.1. Chemotaxis Assay: Version 2Timothy M. Potter, Edward Cedrone, Barry W. Neun, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-6.3. Leukocyte Proliferation Assay: Version 2Timothy M. Potter, Edward Cedrone, Sarah L. Skoczen, Barry W. Neun, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-6.2. Leukocyte Proliferation Assay: Version 2Timothy M. Potter, Edward Cedrone, Sarah L. Skoczen, Barry W. Neun, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-5.2. Analysis of Complement Activation by Single-Plex EIA or Multiplex ELISA: Version 3Barry W. Neun, Edward Cedrone, and Marina A. Dobrovolskaia.Published: May 2020.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Study Samples
- 6. Plasma Collection and Storage
- 7. Experimental Procedure for Sample Preparation
- 8. Experimental Procedure for Single-Plex EIA
- 9. Experimental Procedure for Multi-plex ELISA
- 10. Data Analysis
- 11. Acceptance Criteria
- 12. References
- 13. Abbreviations
- NCL Method ITA-3. Mouse Granulocyte-Macrophage Colony-Forming Unit Assay: Version 4Barry W. Neun, Edward Cedrone, and Marina A. Dobrovolskaia.Published: May 2020.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Animals
- 5. Reagent and Control Preparation
- 6. Preparation of Study Samples
- 7. Isolation and Counting of Bone Marrow Cells
- 8. Experimental Procedure
- 9. Description of CFU-GM
- 10. Calculations
- 11. Acceptance Criteria
- 12. References
- 13. Abbreviations
- NCL Method ITA-2.2. Analysis of Platelet Aggregation by Light Transmission Aggregometry: Version 3Jamie Rodriguez, Barry W. Neun, Edward Cedrone, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-2.1. Analysis of Platelet Aggregation by Cell Counting: Version 4Barry W. Neun, Edward Cedrone, and Marina A. Dobrovolskaia.Published: May 2020.
- NCL Method ITA-1. Analysis of Hemolytic Properties of Nanoparticles: Version 4Barry W. Neun, Edward Cedrone, and Marina A. Dobrovolskaia.Published: May 2020.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Preparation of Standards and Controls
- 5. Preparation of Blood and Study Samples
- 6. Experimental Procedure
- 7. Calculations and Result Interpretation
- 8. Acceptance Criteria
- 9. Example of Nanoparticle Interference
- 10. References
- 11. Abbreviations
- 12. Appendix
- NCL Method IEA-1. Analysis of Nanoparticle Effects on Invasion of Cancer Cells: Version 1.0Julia Bui, Edward Cedrone, Naichen Yu, and Marina A. Dobrovolskaia.Published: May 2020.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, Cell Lines, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Study Samples
- 6. MDA-MB-231 Cell Preparation
- 7. Matrigel Coating of the Upper Chamber of CIM-Plate 16
- 8. Experimental Procedure
- 9. Calculations
- 10. References
- 11. Appendix
- 12. Abbreviations
- NCL Method ITA-35. Antigen-Specific Stimulation of CD8+ T-cells by Murine Bone Marrow-Derived Dendritic Cells: Version 1Enping Hong and Marina A. Dobrovolskaia.Published: February 2019.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Animals
- 5. Reagent and Control Preparation
- 6. Preparation of Nanoparticles
- 7. Isolation and Counting of Bone Marrow Cells
- 8. Generation of Immature Dendritic Cells
- 9. Treatment with Nanoparticles and Controls
- 10. Extraction and Homogenization of OT-I Spleen
- 11. CD8+ T-Cell Labeling and Purification
- 12. Cell Stimulation Experiment
- 13. Assessing T-Cell Purity
- 14. Ending Experiment
- 15. Flow Cytometry
- 16. Data Analysis and Report
- 17. References
- 18. Abbreviations
- 19. Appendix
- NCL Method ITA-34. Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells: Version 1Enping Hong and Marina A. Dobrovolskaia.Published: February 2019.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Animals
- 5. Reagent and Control Preparation
- 6. Preparation of Nanoparticles
- 7. Isolation and Counting of Bone Marrow Cells
- 8. Generation of Immature Dendritic Cells
- 9. Treatment with Nanoparticles and Controls
- 10. Flow Cytometry
- 11. Data Analysis and Report
- 12. References
- 13. Abbreviations
- 14. Appendix
- NCL Method ITA-33. Detection of Changes in Mitochondrial Membrane Potential in T-cells Using JC-1 Dye: Version 1Ankit Shah and Marina A. Dobrovolskaia.Published: February 2019.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Nanoparticles
- 6. Collection and Handling of Whole Blood
- 7. Preparation of T-Cells
- 8. Treatment with Nanoparticles and Controls
- 9. Flow Cytometry
- 10. Data Analysis and Report
- 11. Acceptance criteria
- 12. References
- 13. Abbreviations
- 14. Appendix
- NCL Method ITA-32. Detection of Mitochondrial Oxidative Stress in T-cells Using MitoSOX Red Dye: Version 1Ankit Shah and Marina A. Dobrovolskaia.Published: February 2019.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Nanoparticles
- 6. Collection and Handling of Whole Blood
- 7. Preparation of T-Cells
- 8. Treatment with Nanoparticles and Controls
- 9. Flow Cytometry
- 10. Data Analysis and Report
- 11. Acceptance Criteria
- 12. References
- 13. Abbreviations
- 14. Appendix
- NCL Method ITA-31. Detection of Nanoparticle-Mediated Total Oxidative Stress in T-Cells Using CM-H2DC-FDA Dye: Version 1Ankit Shah and Marina A. Dobrovolskaia.Published: February 2019.
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Reagent and Control Preparation
- 5. Preparation of Nanoparticles
- 6. Collection and Handling of Whole Blood
- 7. Preparation of T-Cells
- 8. Treatment with Nanoparticles and Controls
- 9. Flow Cytometry
- 10. Data Analysis and Report
- 11. Acceptance Criteria
- 12. References
- 13. Abbreviations
- 14. Appendix
- NCL Method ITA-26. Detection of Intracellular Complement Activation in Human T Lymphocytes: Version 1Anna N. Ilinskaya, Ankit Shah, and Marina A. Dobrovolskaia.Published: February 2019.
- NCL Method ITA-37.2. Immunophenotyping: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells: Version 3
- Pharmacology/Toxicology protocols
- Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics & ToxicologyPublished: September 2022.
- NCL Method GTA-1. LLC-PK1 Kidney Cytotoxicity Assay: Version 1.3Stephan T. Stern, Pavan P. Adiseshaiah, and Timothy M. Potter.Published: April 2020.
- NCL Method PHA-1. Radioactive Blood Partitioning Assay: Version 1.1Stephan T. Stern.Published: June 2017.
- NCL Method PHA-2. Ultrafiltration Drug Release Assay Utilizing a Stable Isotope Tracer: Version 1.0Stephan T. Stern and Sarah Skoczen.Published: April 2017.
- NCL Method GTA-3. Hep G2 Hepatocyte Glutathione Assay: Version 1.2Stephan T. Stern, Timothy M. Potter, and Barry W Neun.Published: April 2016.
- NCL Method GTA-14. Hep G2 Hepatocarcinoma Homogeneous Apoptosis Assay: Version 1.2Stephan T. Stern and Barry W. Neun.Published: April 2011.
- NCL Method GTA-12. Autophagic Dysfunction in LLC-PK1 Cells: Version 1.1Stephan T. Stern and Barry W. Neun.Published: February 2011.
- NCL Method GTA-7. Hepatocyte Primary ROS Assay: Version 1.1Stephan T. Stern and Banu S. Zolnik.Published: April 2010.
- NCL Method GTA-6. HepG2 Hepatocarcinoma Apoptosis Assay: Version 1.1Stephan T. Stern and Timothy M. Potter.Published: April 2010.
- NCL Method GTA-5. LLC-PK1 Kidney Cell Apoptosis Assay: Version 1.1Stephan T. Stern and Timothy M. Potter.Published: April 2010.
- NCL Method GTA-4. Hep G2 Hepatocyte Lipid Peroxidation Assay: Version 1.1Stephan T. Stern, Timothy M. Potter, and Barry W Neun.Published: April 2010.
- Guide to NCL In Vivo Studies: Efficacy, Pharmacokinetics & Toxicology
- Physicochemical characterization protocols
- NCL Method PCC-23. Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection: Version 1Krishna Kattel and Jeffrey D. Clogston.Published: August 2023.
- NCL Method PCC-22. Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography: Version 1Krishna Kattel and Jeffrey D. Clogston.Published: September 2022.
- Parameters, Methods and Considerations for the Physicochemical Characterization of Colloidal Metal NanoparticlesPublished: June 2022.
- Parameters, Methods and Considerations for the Physicochemical Characterization of Polymeric NanoparticlesPublished: June 2022.
- Parameters, Methods and Considerations for the Physicochemical Characterization of Liposomal ProductsJeffrey D. Clogston.Published: June 2022.
- NCL Method PCC-21. Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS: Version 1Matthew Hansen and Jeffrey D. Clogston.Published: January 2021.
- NCL Method PCC-19. Asymmetric-Flow Field-Flow Fractionation: Version 1.0Jeffrey D. Clogston and Yingwen Hu.Published: May 2020.
- NCL Method PCC-18. Quantitation of APIs in Polymeric Prodrug Formulations: Version 1.0Jeffrey D. Clogston and Yingwen Hu.Published: May 2020.
- NCL Method PCC-2. Measuring Zeta Potential of Nanoparticles: Version 1.2Jeffrey D. Clogston and Alison Vermilya.Published: April 2020.
- NCL Method PCC-16. Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection: Version 1.0Jeffrey D. Clogston and Mackensie C. Smith.Published: October 2017.
- NIST - NCL Joint Assay Protocol, PCC-15. Measuring the Size of Colloidal Gold Nano-particles using High-Resolution Scanning Electron Microscopy: Version 1.0András E. Vladár and Bin Ming.Published: July 2011.
- NIST - NCL Joint Assay Protocol, PCC-14. Quantification of Free and Chelated Gadolinium Species in Nanoemulsion-Based Magnetic Resonance Imaging Contrast Agent Formulations using Hyphenated Chromatography Methods: Version 1.0Danielle Cleveland.Published: June 2010.
- 1. Introduction
- 2. Reagents and Equipment
- 3. Reagent Preparation
- 4. Measurement of Total Gadolinium by ID-ICP-MS
- 5. Reversed-Phase Liquid Chromatography with Fluorescence Detection and on-line ID-ICP-MS
- 6. High Pressure Size Exclusion Chromatography with Online ID-ICP-MS Detection
- 7. High-Pressure Size Exclusion Chromatography SID-ICP-MS Analysis
- 8. References
- 9. Abbreviations
- Appendix A. Uncertainty for ICP-MS Measurements
- Appendix B. Procedure for Day-to-Day Use of Analytical Balances
- NIST - NCL Joint Assay Protocol, PCC-13. Measuring the pH of Nanoparticle Suspensions: Version 1.1Kenneth W. Pratt.Published: March 2010.
- NIST - NCL Joint Assay Protocol, PCC-12. Measuring the Electrolytic Conductivity of Nanoparticle Suspensions: Version 1.1Kenneth W. Pratt.Published: March 2010.
- NIST - NCL Joint Assay Protocol, PCC-10. Analysis of Gold Nanoparticles by Electrospray Differential Mobility Analysis (ES-DMA): Version 1.1Leonard F. Pease, III, De-Hao Tsai, Rebecca A. Zangmeister, Michael R. Zachariah, and Michael J. Tarlov.Published: March 2010.
- NIST - NCL Joint Assay Protocol, PCC-9. Determination of Gold in Rat Blood with Inductively Coupled Plasma Mass Spectrometry: Version 1.1L.L. Yu, L.J. Wood, and S.E. Long.Published: February 2010.
- 1. Introduction
- 2. Reagents and Equipment
- 3. Digestion of Blood
- 4. Preparation of Analytical Portions
- 5. ICP-MS Measurements
- 6. Calculations
- 7. Abbreviations
- Appendix A. Setup and Optimization Procedure for Agilent 7500cs ICP Mass Spectrometer
- Appendix B. Procedure for Use of Balances
- Appendix C. Microwave Digestion
- NIST - NCL Joint Assay Protocol, PCC-8. Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry: Version 1.1L.L. Yu, L.J. Wood, and S.E. Long.Published: February 2010.
- 1. Introduction
- 2. Reagents and Equipment
- 3. Digestion of Tissue
- 4. Preparation of Analytical Portions
- 5. ICP-MS Measurements
- 6. Calculations
- 7. Abbreviations
- Appendix A. Setup and Optimization Procedure for Agilent 7500cs ICP Mass Spectrometer
- Appendix B. Procedure for Use of Balances
- Appendix C. Microwave Digestion
- NIST - NCL Joint Assay Protocol, PCC-7. Measuring the Size of Nanoparticles Using Transmission Electron Microscopy (TEM): Version 1.1John E. Bonevich and Wolfgang K. Haller.Published: February 2010.
- NIST - NCL Joint Assay Protocol, PCC-1. Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering: Version 1.1Vincent A. Hackley and Jeffrey D. Clogston.Published: February 2010.
- NIST - NCL Joint Assay Protocol, PCC-6. Size Measurement of Nanoparticles Using Atomic Force Microscopy: Version 1.1Jaroslaw Grobelny, Frank W. DelRio, Namboodiri Pradeep, Doo-In Kim, Vincent A. Hackley, and Robert F. Cook.Published: October 2009.
- NCL Method PCC-23. Quantitation of Residual DMSO in Nanoformulations Using Gas Chromatography with Direct Injection and Flame Ionization Detection: Version 1
- Sterility and endotoxin protocols
- Endotoxin & Depyrogenation TipsPublished: June 2023.
- NCL Method STE-3. Detection of Mycoplasma Contamination in Nanoparticle Formulations: Version 3Timothy M. Potter, Barry W. Neun, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method STE-2.4. Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID: Version 2Barry W. Neun, Edward Cedrone, Timothy M. Potter, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method STE-2.3. Detection of Bacterial Contamination Using Tryptic Soy Broth Agar Plates: Version 3Barry W. Neun, Timothy M. Potter, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method STE-2.2. Detection of Bacterial Contamination Using Luria Broth Agar Plates: Version 3Barry W. Neun, Timothy M. Potter, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method STE-2.1. Detection of Microbial Contamination Using Millipore Sampler Devices: Version 3Barry W. Neun, Timothy M. Potter, and Marina A. Dobrovolskaia.Published: September 2020.
- NCL Method STE-4. Detection and Quantification of β-(1,3)-D-Glucan Contamination in Nanoparticle Formulations by Factor C Depleted LAL (Glucatell®) Assay: Version 1Barry W. Neun and Marina A. Dobrovolskaia.Published: June 2020.
- Endotoxin & Depyrogenation Tips
- NLM CatalogRelated NLM Catalog Entries
- Review The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.[Curr Med Chem. 2018]Review The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F. Curr Med Chem. 2018; 25(34):4224-4268.
- Review Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.[Eur J Pharm Biopharm. 2015]Review Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Pérez-Herrero E, Fernández-Medarde A. Eur J Pharm Biopharm. 2015 Jun; 93:52-79. Epub 2015 Mar 23.
- Review Pharmacokinetics of nanotechnology-based formulations in pediatric populations.[Adv Drug Deliv Rev. 2019]Review Pharmacokinetics of nanotechnology-based formulations in pediatric populations.Yellepeddi VK, Joseph A, Nance E. Adv Drug Deliv Rev. 2019 Nov-Dec; 151-152:44-55. Epub 2019 Sep 5.
- Review General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.[J Drug Target. 2018]Review General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.Wakaskar RR. J Drug Target. 2018 Apr; 26(4):311-318. Epub 2017 Aug 18.
- Review Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.[J Chromatogr A. 2021]Review Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.Caputo F, Mehn D, Clogston JD, Rösslein M, Prina-Mello A, Borgos SE, Gioria S, Calzolai L. J Chromatogr A. 2021 Jan 4; 1635:461767. Epub 2020 Nov 27.
- National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cas...National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols
Your browsing activity is empty.
Activity recording is turned off.
See more...